SCHEMBL6838244

SCHEMBL6838244

N#Cc1ccc(COC(=O)c2ccc3ncc(Cc4ccc(C(=O)O)cc4)c(O)c3c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.48
TSHR P16473 1/20 0.41
USP2 O75604 1/20 0.41
PKM P14618 1/20 0.41
ALDH1A1 P00352 1/20 0.40
ABCB1 P08183 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
ALKBH1 Q13686 1/20 0.39
EGLN1 Q9GZT9 1/20 0.39
KDM5A P29375 1/20 0.38
KDM2B Q8NHM5 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
KDM5B Q9UGL1 1/20 0.38
RAB9A P51151 1/20 0.36
PAX8 Q06710 1/20 0.36
SLC22A12 Q96S37 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6196320 0.89 LMNA (0.46) TDP1TSHRALDH1A1MAPTRAB9A
SCHEMBL6843378 0.87 NR4A2 (0.44) MAPTALKBH1KDM5AKDM4CKDM5B
SCHEMBL6845415 0.87 PAX8 (0.42) PKMALDH1A1MAPTPAX8MEN1
SCHEMBL6842986 0.87 NR4A2 (0.44) TDP1ALDH1A1MAPTPAX8MEN1
SCHEMBL6844771 0.87 RXRA (0.44) TDP1ALDH1A1MAPTRAB9APAX8
SCHEMBL6842398 0.87 MAPT (0.41) TDP1TSHRMAPTRAB9APAX8
SCHEMBL6843455 0.87 RXRA (0.44) PKMALDH1A1MAPTRAB9APAX8
SCHEMBL6193976 0.85 SMN1; SMN2 (0.48) MAPTRAB9APAX8MEN1KMT2A
SCHEMBL6838124 0.85 TP53 (0.38) TSHRPKMALDH1A1MAPTRAB9A
SCHEMBL6838199 0.85 RXRA (0.46) ALDH1A1MAPTKDM5AKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040043983-A1 Naphthalene derivatives as matrix metalloproteinase inhibitors LI JIE JACK (US) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040043983-A1 Naphthalene derivatives as matrix metalloproteinase inhibitors MMP9, MMP8, MMP13 TDP1 1549/4885TSHR 3787/4885USP2 1487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.